10.07.2010: Mid-day update pps $1.67 In the phase III study, Spherix’s monotherapy D-tagatose significantly reduced levels of glycated hemoglobin, or HbA1c, a protein in red blood cells formed when blood sugar attaches to hemoglobin, at 10 months of treatment in relatively healthy people with diabetes. While lower levels of HbA1c in the blood are considered […]